Manuel Rodriguez
Foot & Ankle Surgery · South Miami, FLNPI 1477729846
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Organogenesis Inc. accounts for 81.8% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $1,623, 2.3 times the $699 reported in 2019.
Across 149 payments — averaging $37.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$5K
- DJO, LLC$289
- Integra Lifesciences Corporation$230
- KCI USA, Inc.$85
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$83
- Smith+Nephew$57
- plus $270 from 8 others
Across 25 payments — averaging $8624.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Organogenesis Inc.$141K
- Endo Pharmaceuticals Inc.$74K
What the payments were for
- Travel & lodging$1152%
- Food & beverage$5,46698%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 98 | $4,566 |
| DJO, LLC | 21 | $289 |
| Integra Lifesciences Corporation | 10 | $230 |
| KCI USA, Inc. | 4 | $85 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $83 |
| Smith+Nephew | 2 | $57 |
| Next Science LLC | 1 | $51 |
| Mimedx Group, Inc. | 1 | $50 |
| Amgen | 2 | $44 |
| ETS Wound Care LLC | 2 | $40 |
| Reprise Biomedical, Inc. | 1 | $38 |
| Alfasigma USA, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,581 in reported general payments places this provider in the 60th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 66 | $434 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $313 |
| SsdSilver Sulfadiazine | 19 | $193 |
| Ketoconazole | 13 | $180 |
| Ibuprofen | 17 | $126 |
| Doxycycline Hyclate | 19 | $81 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in South Miami
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
- Christopher ReevesLake Mary$424K
- Ettore VulcanoMiami Beach$411K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.